Revolution Medicines, Inc. (NASDAQ:RVMD) Q3 2022 Earnings Call Transcript November 7, 2022
Revolution Medicines, Inc. misses on earnings expectations. Reported EPS is $-0.87 EPS, expectations were $-0.84.
Operator: Good day and thank you for standing by. Welcome to the Revolution Medicines Third Quarter 2022 Earnings Webcast. I would now like to hand the conference over to Peg Horn, Revolution Medicine’s Chief Operating Officer for opening remarks. Peg, you may begin.
Photo by Hans Reniers...
